265 related articles for article (PubMed ID: 23049784)
1. NADPH oxidase NOX4 mediates stellate cell activation and hepatocyte cell death during liver fibrosis development.
Sancho P; Mainez J; Crosas-Molist E; Roncero C; Fernández-Rodriguez CM; Pinedo F; Huber H; Eferl R; Mikulits W; Fabregat I
PLoS One; 2012; 7(9):e45285. PubMed ID: 23049784
[TBL] [Abstract][Full Text] [Related]
2. Liver fibrosis and hepatocyte apoptosis are attenuated by GKT137831, a novel NOX4/NOX1 inhibitor in vivo.
Jiang JX; Chen X; Serizawa N; Szyndralewiez C; Page P; Schröder K; Brandes RP; Devaraj S; Török NJ
Free Radic Biol Med; 2012 Jul; 53(2):289-96. PubMed ID: 22618020
[TBL] [Abstract][Full Text] [Related]
3. Deficiency of NOX1 or NOX4 Prevents Liver Inflammation and Fibrosis in Mice through Inhibition of Hepatic Stellate Cell Activation.
Lan T; Kisseleva T; Brenner DA
PLoS One; 2015; 10(7):e0129743. PubMed ID: 26222337
[TBL] [Abstract][Full Text] [Related]
4. Activated hepatic stellate cells and portal fibroblasts contribute to cholestatic liver fibrosis in MDR2 knockout mice.
Nishio T; Hu R; Koyama Y; Liang S; Rosenthal SB; Yamamoto G; Karin D; Baglieri J; Ma HY; Xu J; Liu X; Dhar D; Iwaisako K; Taura K; Brenner DA; Kisseleva T
J Hepatol; 2019 Sep; 71(3):573-585. PubMed ID: 31071368
[TBL] [Abstract][Full Text] [Related]
5. Nicotinamide adenine dinucleotide phosphate oxidase in experimental liver fibrosis: GKT137831 as a novel potential therapeutic agent.
Aoyama T; Paik YH; Watanabe S; Laleu B; Gaggini F; Fioraso-Cartier L; Molango S; Heitz F; Merlot C; Szyndralewiez C; Page P; Brenner DA
Hepatology; 2012 Dec; 56(6):2316-27. PubMed ID: 22806357
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis C virus (HCV) proteins induce NADPH oxidase 4 expression in a transforming growth factor beta-dependent manner: a new contributor to HCV-induced oxidative stress.
Boudreau HE; Emerson SU; Korzeniowska A; Jendrysik MA; Leto TL
J Virol; 2009 Dec; 83(24):12934-46. PubMed ID: 19812163
[TBL] [Abstract][Full Text] [Related]
7. NADPH oxidase 4 (Nox4) deletion accelerates liver regeneration in mice.
Herranz-Itúrbide M; López-Luque J; Gonzalez-Sanchez E; Caballero-Díaz D; Crosas-Molist E; Martín-Mur B; Gut M; Esteve-Codina A; Jaquet V; Jiang JX; Török NJ; Fabregat I
Redox Biol; 2021 Apr; 40():101841. PubMed ID: 33493901
[TBL] [Abstract][Full Text] [Related]
8. Protein tyrosine phosphatase 1b deficiency protects against hepatic fibrosis by modulating nadph oxidases.
García-Ruiz I; Blanes Ruiz N; Rada P; Pardo V; Ruiz L; Blas-García A; Valdecantos MP; Grau Sanz M; Solís Herruzo JA; Valverde ÁM
Redox Biol; 2019 Sep; 26():101263. PubMed ID: 31299613
[TBL] [Abstract][Full Text] [Related]
9. Role of NADPH oxidases in the redox biology of liver fibrosis.
Crosas-Molist E; Fabregat I
Redox Biol; 2015 Dec; 6():106-111. PubMed ID: 26204504
[TBL] [Abstract][Full Text] [Related]
10. Exosome-Mediated Intercellular Communication between Hepatitis C Virus-Infected Hepatocytes and Hepatic Stellate Cells.
Devhare PB; Sasaki R; Shrivastava S; Di Bisceglie AM; Ray R; Ray RB
J Virol; 2017 Mar; 91(6):. PubMed ID: 28077652
[TBL] [Abstract][Full Text] [Related]
11. Hepatocyte NAD(P)H oxidases as an endogenous source of reactive oxygen species during hepatitis C virus infection.
de Mochel NS; Seronello S; Wang SH; Ito C; Zheng JX; Liang TJ; Lambeth JD; Choi J
Hepatology; 2010 Jul; 52(1):47-59. PubMed ID: 20578128
[TBL] [Abstract][Full Text] [Related]
12. EGF blocks NADPH oxidase activation by TGF-beta in fetal rat hepatocytes, impairing oxidative stress, and cell death.
Carmona-Cuenca I; Herrera B; Ventura JJ; Roncero C; Fernández M; Fabregat I
J Cell Physiol; 2006 May; 207(2):322-30. PubMed ID: 16331683
[TBL] [Abstract][Full Text] [Related]
13. CYLD Deubiquitinates Nicotinamide Adenine Dinucleotide Phosphate Oxidase 4 Contributing to Adventitial Remodeling.
Yu B; Liu Z; Fu Y; Wang Y; Zhang L; Cai Z; Yu F; Wang X; Zhou J; Kong W
Arterioscler Thromb Vasc Biol; 2017 Sep; 37(9):1698-1709. PubMed ID: 28751569
[TBL] [Abstract][Full Text] [Related]
14. Dissecting the role of the NADPH oxidase NOX4 in TGF-beta signaling in hepatocellular carcinoma.
Espinosa-Sotelo R; Fusté NP; Peñuelas-Haro I; Alay A; Pons G; Almodóvar X; Albaladejo J; Sánchez-Vera I; Bonilla-Amadeo R; Dituri F; Serino G; Ramos E; Serrano T; Calvo M; Martínez-Chantar ML; Giannelli G; Bertran E; Fabregat I
Redox Biol; 2023 Sep; 65():102818. PubMed ID: 37463530
[TBL] [Abstract][Full Text] [Related]
15. Upregulation of the NADPH oxidase NOX4 by TGF-beta in hepatocytes is required for its pro-apoptotic activity.
Carmona-Cuenca I; Roncero C; Sancho P; Caja L; Fausto N; Fernández M; Fabregat I
J Hepatol; 2008 Dec; 49(6):965-76. PubMed ID: 18845355
[TBL] [Abstract][Full Text] [Related]
16. Upregulation of cannabinoid receptor-1 and fibrotic activation of mouse hepatic stellate cells during Schistosoma J. infection: role of NADPH oxidase.
Wang M; Abais JM; Meng N; Zhang Y; Ritter JK; Li PL; Tang WX
Free Radic Biol Med; 2014 Jun; 71():109-120. PubMed ID: 24657416
[TBL] [Abstract][Full Text] [Related]
17. Targeting of NADPH oxidase in vitro and in vivo suppresses fibroblast activation and experimental skin fibrosis.
Dosoki H; Stegemann A; Taha M; Schnittler H; Luger TA; Schröder K; Distler JH; Kerkhoff C; Böhm M
Exp Dermatol; 2017 Jan; 26(1):73-81. PubMed ID: 27576129
[TBL] [Abstract][Full Text] [Related]
18. The nicotinamide adenine dinucleotide phosphate oxidase (NOX) homologues NOX1 and NOX2/gp91(phox) mediate hepatic fibrosis in mice.
Paik YH; Iwaisako K; Seki E; Inokuchi S; Schnabl B; Osterreicher CH; Kisseleva T; Brenner DA
Hepatology; 2011 May; 53(5):1730-41. PubMed ID: 21384410
[TBL] [Abstract][Full Text] [Related]
19. β-Arrestin2 deficiency attenuates oxidative stress in mouse hepatic fibrosis through modulation of NOX4.
Du JJ; Sun JC; Li N; Li XQ; Sun WY; Wei W
Acta Pharmacol Sin; 2021 Jul; 42(7):1090-1100. PubMed ID: 33116250
[TBL] [Abstract][Full Text] [Related]
20. Exogenous 8-hydroxydeoxyguanosine ameliorates liver fibrosis through the inhibition of Rac1-NADPH oxidase signaling.
Shin SK; Kim KO; Kim SH; Kwon OS; Choi CS; Jeong SH; Kim YS; Kim JH; Chung MH
J Gastroenterol Hepatol; 2020 Jun; 35(6):1078-1087. PubMed ID: 31907970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
